Osteoporosis and fracture risk: Bone matrix quality

Journal of Musculoskeletal Neuronal Interactions

Volumn 2, Issue 6, 2002, Pages 525-526

  Burr, D B ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomechanics; Bisphosphonates; Collagen; Mineralization; Remodeling

Indexed keywords

ALENDRONIC ACID; CALCITONIN; COLLAGEN; ESTRADIOL; ETIDRONIC ACID; MINERAL; RALOXIFENE; RISEDRONIC ACID; TILUDRONIC ACID;

ARTICLE; BIOCHEMISTRY; BONE DENSITY; BONE MASS; BONE MATRIX; BONE MINERAL; BONE TISSUE; BONE TURNOVER; CLINICAL TRIAL; FRAGILITY FRACTURE; HUMAN; INCIDENCE; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; RISK ASSESSMENT; TURNOVER TIME;

EID: 0036978407     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996; 348:1535-1541.
2. Pols MAP, Felsenberg D, Hanley DA, Stepan I, Munoz-Torres M, Wilkin TJ. Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study. Osteoporos Int 1999; 9:461-468.
3. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD. [For the VERT Study Group]. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. JAMA 1999; 282:1344-1352.
4. Delmas PD. How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis? Bone 2000; 27:1-3.
5. Black DM, Pearson J, Harris F, LaCroix A, Cummings SR. Predicting the effect of antiresorptive treatments on risk of vertebral fractures: A meta-analysis. J Bone Miner Res 1999; 14(Suppl):S137.
6. McClung MR. Therapy for fracture prevention. JAMA 1999; 282:687-688.
7. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR. Reduction of fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999; 282:637-645.
8. Chesnut CH. QUEST study. Personal communication.